We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now


It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers

WINT Windtree Therapeutics Inc

-0.04 (-3.54%)
Dec 02 2023 - Closed
Delayed by 15 minutes


Draw Mode:

Volume 161,756
Bid Price 0.94
Ask Price 1.09
News -
Day High 1.11


52 Week Range


Day Low 1.0014
Company Name Stock Ticker Symbol Market Type
Windtree Therapeutics Inc WINT NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.04 -3.54% 1.09 00:00:10
Open Price Low Price High Price Close Price Prev Close
1.11 1.0014 1.11 1.05 1.13
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
385 161,756 $ 1.05 $ 169,568 - 0.86 - 19.055
Last Trade Time Type Quantity Stock Price Currency
18:43:47 10 $ 1.09 USD

Windtree Therapeutics Inc Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
5.41M 5.15M - 0 -39.21M -7.62 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

Windtree Therapeutics News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....

No posts yet, be the first! No WINT Message Board. Create One! See More Posts on WINT Message Board See More Message Board Posts

Historical WINT Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week0.95381.24230.911.04152,8610.136214.28%
1 Month0.99021.24230.900.9893591102,5890.099810.08%
3 Months1.091.500.861.12106,0070.000.0%
6 Months1.271.950.861.39182,343-0.18-14.17%
1 Year9.95519.0550.869.381,193,667-8.87-89.05%
3 Years318.50334.500.8654.651,020,134-317.41-99.66%
5 Years347.50503.000.8656.93871,314-346.41-99.69%

Windtree Therapeutics Description

Windtree Therapeutics Inc is a development-stage biotechnology company focused on developing KL4 surfactant therapies for respiratory diseases. Its technology platform includes synthetic, peptide-containing surfactant and novel drug delivery technologies that deliver aerosolized KL4 surfactants without invasive procedures. Its development program utilizing its proprietary technology platform is AEROSURF which is being developed for the treatment of respiratory distress syndrome in premature infants. It operates in the business segment of research and development of products focused on surfactant therapies for respiratory disorders and diseases, and the manufacture and commercial sales of approved products.

Your Recent History

Delayed Upgrade Clock

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

Support: 1-888-992-3836 |